ARATANA THERAPEUTICS, INC. 4
4 · ARATANA THERAPEUTICS, INC. · Filed Jul 3, 2013
Insider Transaction Report
Form 4
MAWHINNEY LOUISE
CHIEF FINANCIAL OFFICER
Transactions
- Conversion
COMMON STOCK
2013-07-02+7,521→ 50,769 total - Conversion
SERIES C CONVERTIBLE PREFERRED STOCK
2013-07-02−12,500→ 0 totalExercise: $6.65→ COMMON STOCK (7,521 underlying)
Footnotes (2)
- [F1]Series C Convertible Preferred Stock (the "Preferred Stock") has no expiration date. The shares of Preferred Stock reported on this line item converted into shares of the Issuer's Common Stock on a 1-for-0.601685 basis upon the closing of the Issuer's initial public offering (the "IPO Closing").
- [F2]The reporting person acquired an aggregate of 277 shares of common stock as a stock dividend on the IPO Closing which are reflected in the aggregate holdings set forth in Column 5.